Patient#	Sample#	CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment:(STAT5 (dimer)-active, active),	BCL2:(BCL2, protein),	BCL2L1:(BCL2L1, protein),	CCNA2:(CCNA2, protein),	CCND3:(CCND3, protein),	CDK6:(CDK6, protein),	FASLG:(FASLG, protein),	IL4:(IL4, protein),	LTA:(LTA, protein),	MYC:(MYC, protein),	PRF1:(PRF1, protein),	ELF1:(ELF1, protein),	FOXP3:(FOXP3, protein),	SP1:(SP1, protein),	activation-induced cell death of T cells:(BCL2, active),(BCL2L1, active),(STAT5 (dimer)-active, active),	cell proliferation:(MYC, active),	CCND2:(CCND2, protein),	IL2RA:(IL2RA, protein),	G1/S transition of mitotic cell cycle:(CCNA2, active),(CCND2, active),(CCND3, active),(CDK6, active),	
